Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy

Background Ivabradine is a negative chronotropic drug with minimal effects on central hemodynamics. Its effect on dynamic obstruction of the left ventricular outflow tract (LVOT) in cats with hypertrophic cardiomyopathy (HCM) remains unknown. Hypothesis/Objectives Ivabradine reduces dynamic obstruct...

Full description

Bibliographic Details
Main Authors: K.A. Blass, K.E. Schober, X. Li, B.A. Scansen, J.D. Bonagura
Format: Article
Language:English
Published: Wiley 2014-05-01
Series:Journal of Veterinary Internal Medicine
Subjects:
Online Access:https://doi.org/10.1111/jvim.12331
_version_ 1798029548166578176
author K.A. Blass
K.E. Schober
X. Li
B.A. Scansen
J.D. Bonagura
author_facet K.A. Blass
K.E. Schober
X. Li
B.A. Scansen
J.D. Bonagura
author_sort K.A. Blass
collection DOAJ
description Background Ivabradine is a negative chronotropic drug with minimal effects on central hemodynamics. Its effect on dynamic obstruction of the left ventricular outflow tract (LVOT) in cats with hypertrophic cardiomyopathy (HCM) remains unknown. Hypothesis/Objectives Ivabradine reduces dynamic obstruction of the LVOT in cats with HCM. Animals Twenty‐eight client‐owned cats with preclinical HCM and dynamic LVOT obstruction. Methods Randomized, double‐blind, active‐control single dose study. Cats received a single dose of either ivabradine (0.3 mg/kg PO) or atenolol (2 mg/kg PO). Heart rate, echocardiographic variables, and systolic blood pressure (SBP) were recorded before and 3 hours after drug administration. Statistical comparisons were made using ANCOVA. Results Peak velocity in the LVOT was significantly decreased compared to baseline for both drugs; however, the effect was more prominent with atenolol (mean reduction 2.53 m/s; 95% CI 2.07–3.13 m/s) compared to ivabradine (mean reduction 0.32 m/s; 95% CI −0.04 to 0.71 m/s; P < .0001). Echocardiographic indices of systolic function were largely unchanged by ivabradine, but significantly reduced by atenolol. Conclusions and Clinical Importance A single dose of ivabradine decreases dynamic LVOT obstruction in cats with HCM, but the clinical effect is negligible and inferior compared to that achieved by atenolol.
first_indexed 2024-04-11T19:25:54Z
format Article
id doaj.art-effcc142be65432b9ca89743125368fe
institution Directory Open Access Journal
issn 0891-6640
1939-1676
language English
last_indexed 2024-04-11T19:25:54Z
publishDate 2014-05-01
publisher Wiley
record_format Article
series Journal of Veterinary Internal Medicine
spelling doaj.art-effcc142be65432b9ca89743125368fe2022-12-22T04:07:09ZengWileyJournal of Veterinary Internal Medicine0891-66401939-16762014-05-0128383884610.1111/jvim.12331Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic CardiomyopathyK.A. Blass0K.E. Schober1X. Li2B.A. Scansen3J.D. Bonagura4Department of Veterinary Clinical Sciences College of Veterinary MedicineThe Ohio State UniversityColumbusOHDepartment of Veterinary Clinical Sciences College of Veterinary MedicineThe Ohio State UniversityColumbusOHCenter for Biostatistics Office of Health Sciences The Ohio State University Columbus OHDepartment of Veterinary Clinical Sciences College of Veterinary MedicineThe Ohio State UniversityColumbusOHDepartment of Veterinary Clinical Sciences College of Veterinary MedicineThe Ohio State UniversityColumbusOHBackground Ivabradine is a negative chronotropic drug with minimal effects on central hemodynamics. Its effect on dynamic obstruction of the left ventricular outflow tract (LVOT) in cats with hypertrophic cardiomyopathy (HCM) remains unknown. Hypothesis/Objectives Ivabradine reduces dynamic obstruction of the LVOT in cats with HCM. Animals Twenty‐eight client‐owned cats with preclinical HCM and dynamic LVOT obstruction. Methods Randomized, double‐blind, active‐control single dose study. Cats received a single dose of either ivabradine (0.3 mg/kg PO) or atenolol (2 mg/kg PO). Heart rate, echocardiographic variables, and systolic blood pressure (SBP) were recorded before and 3 hours after drug administration. Statistical comparisons were made using ANCOVA. Results Peak velocity in the LVOT was significantly decreased compared to baseline for both drugs; however, the effect was more prominent with atenolol (mean reduction 2.53 m/s; 95% CI 2.07–3.13 m/s) compared to ivabradine (mean reduction 0.32 m/s; 95% CI −0.04 to 0.71 m/s; P < .0001). Echocardiographic indices of systolic function were largely unchanged by ivabradine, but significantly reduced by atenolol. Conclusions and Clinical Importance A single dose of ivabradine decreases dynamic LVOT obstruction in cats with HCM, but the clinical effect is negligible and inferior compared to that achieved by atenolol.https://doi.org/10.1111/jvim.12331AtenololFelineIf currentSystolic anterior motion
spellingShingle K.A. Blass
K.E. Schober
X. Li
B.A. Scansen
J.D. Bonagura
Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy
Journal of Veterinary Internal Medicine
Atenolol
Feline
If current
Systolic anterior motion
title Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy
title_full Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy
title_fullStr Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy
title_full_unstemmed Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy
title_short Acute Effects of Ivabradine on Dynamic Obstruction of the Left Ventricular Outflow Tract in Cats with Preclinical Hypertrophic Cardiomyopathy
title_sort acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy
topic Atenolol
Feline
If current
Systolic anterior motion
url https://doi.org/10.1111/jvim.12331
work_keys_str_mv AT kablass acuteeffectsofivabradineondynamicobstructionoftheleftventricularoutflowtractincatswithpreclinicalhypertrophiccardiomyopathy
AT keschober acuteeffectsofivabradineondynamicobstructionoftheleftventricularoutflowtractincatswithpreclinicalhypertrophiccardiomyopathy
AT xli acuteeffectsofivabradineondynamicobstructionoftheleftventricularoutflowtractincatswithpreclinicalhypertrophiccardiomyopathy
AT bascansen acuteeffectsofivabradineondynamicobstructionoftheleftventricularoutflowtractincatswithpreclinicalhypertrophiccardiomyopathy
AT jdbonagura acuteeffectsofivabradineondynamicobstructionoftheleftventricularoutflowtractincatswithpreclinicalhypertrophiccardiomyopathy